SANOFICONR — Sanofi Consumer Healthcare India Income Statement
0.000.00%
Last trade - 00:00- IN₹94.09bn
- IN₹90.59bn
- IN₹8.78bn
Annual income statement for Sanofi Consumer Healthcare India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 5,554 | 7,245 | 8,784 |
| Cost of Revenue | |||
| Gross Profit | 4,033 | 5,383 | 6,483 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 3,402 | 4,868 | 5,745 |
| Operating Profit | 2,152 | 2,377 | 3,039 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 2,193 | 2,468 | 3,203 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 1,649 | 1,810 | 2,401 |
| Net Income Before Extraordinary Items | |||
| Net Income | 1,649 | 1,810 | 2,401 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 1,649 | 1,810 | 2,401 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 72.2 | 87.6 | 102 |
| Dividends per Share |